Journal: Cellular and Molecular Gastroenterology and Hepatology
Article Title: cccDNA Surrogate MC-HBV–Based Screen Identifies Cohesin Complex as a Novel HBV Restriction Factor
doi: 10.1016/j.jcmgh.2022.08.002
Figure Lengend Snippet: siRNA and Primers in This Study
Article Snippet: The commercial antibodies used for Western blot in this study were as follows: rabbit anti-SMC3 monoclonal antibody (1:2000, 5696; Cell Signaling Technology, Danvers, MA), rabbit anti-SMC1A monoclonal antibody (1:10,000, ab109238; Abcam, Cambridge, MA), rabbit anti-CTCF polyclonal antibody (1:4000, ab188408; Abcam), rabbit anti-HBc polyclonal antibody (1:2000, B0586; Dako, Copenhagen, Denmark), rabbit anti-HBx polyclonal antibody (1:2000, ab39716; Abcam), mouse anti-PDS5B monoclonal antibody (1:50, SC-81635; Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-PDS5A monoclonal antibody (1:50, SC-515263; Santa Cruz Biotechnology), mouse anti-RAD21 monoclonal antibody (1:50, SC-271601; Santa Cruz Biotechnology), mouse anti–β-actin monoclonal antibody (1:5000, 66009-I-Ig; Proteintech, Chicago, IL), mouse anti–glyceraldehyde 3-phosphate dehydrogenase (GAPDH) monoclonal antibody (1:5000, 66004-I-Ig; Proteintech), mouse anti-Flag-tag monoclonal antibody (1:1000, M2; Sigma), and mouse anti-HA-tag monoclonal antibody (1:2000, ab130275; Abcam).
Techniques: Sequencing